Signalling between microvascular endothelium and cardiomyocytes through neuregulin

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 194-204

  Parodi, Emily M ^a   Kuhn, Bernhard ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

ErbB; Heart; Heterocellular communication; Neuregulin

Indexed keywords

ANGIOTENSIN II; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; NEU DIFFERENTIATION FACTOR; NEURITE PROMOTING FACTOR; PHENYLEPHRINE; PROTEIN KINASE C; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UROCORTIN; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; AORTA CONSTRICTION; APOPTOSIS; BREAST CANCER; BREAST DEVELOPMENT; CANCER INCIDENCE; CANCER PROGNOSIS; CARBOXY TERMINAL SEQUENCE; CARDIOMYOPATHY; CARDIOTOXICITY; CELL FUNCTION; CELL SURFACE; CHROMOSOME 8; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DIMERIZATION; DISEASE COURSE; DISEASE SEVERITY; ENDOCARDIUM; EXTRACELLULAR SPACE; FIBROBLAST; GENE AMPLIFICATION; GENETIC SCREENING; HEART; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC STRESS; HIRSCHSPRUNG DISEASE; HOMEOSTASIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IN VITRO STUDY; INTERNALIZATION; KRINGLE DOMAIN; MECHANICAL STRESS; MICROVASCULAR ENDOTHELIAL CELL; MICROVASCULATURE; NONHUMAN; PHENOTYPE; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SCAR FORMATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UPREGULATION; VENTRICULAR NONCOMPACTION; ANIMAL; ENDOTHELIUM; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ENDOTHELIUM; HEART DISEASES; HUMANS; MICROVESSELS; MYOCYTES, CARDIAC; NEUREGULINS; SIGNAL TRANSDUCTION;

EID: 84897511037     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu021     Document Type: Review

References (157)

1. Peles E Yarden Y. Neu and its ligands: From an oncogene to neural factors. BioEssays News Rev Mol Cell Dev Biol 1993;15:815-824
2. Carraway KL IIIWeber JL Unger MJ Ledesma J Yu N GassmannMet al. Neuregulin-2 a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 1997;387:512-516
3. Zhang D Sliwkowski MX Mark M Frantz G Akita R Sun Y et al. Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 1997;94:9562-9567
4. Harari D Tzahar E Romano J Shelly M Pierce JH Andrews GC et al. Neuregulin-4: A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 1999;18:2681-2689
5. Hidalgo A Kinrade EF Georgiou M. The Drosophila neuregulin vein maintains glial survival during axon guidance in the CNS. Dev Cell 2001;1:679-690
6. Honjo Y Kniss J Eisen JS. Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons. Dev Camb Engl 2008;135:2615-2625
7. Yang JFZhou H Pun S IpNY Peng HB TsimKW. Cloning ofcDNAsencoding xenopus neuregulin: Expression in myotomal muscle during embryo development. Brain Res Mol Brain Res 1998;58:59-73
8. Brockes JP. Glial growth factor-A new component of the brain and pituitary. Birth Defects Orig Artic Ser 1983;19:277-285
9. Lemke GE Brockes JP. Identification and purification of glial growth factor. J Neurosci Off J Soc Neurosci 1984;4:75-83
10. Marchionni MA Goodearl AD Chen MS Bermingham-McDonogh O Kirk C Hendricks M et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 1993;362:312-318
11. Orr-Urtreger A Trakhtenbrot L Ben-Levy RWen D Rechavi G Lonai P et al. Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. Proc Natl Acad Sci USA 1993;90:1867-1871
12. Peles E Bacus SS Koski RA Lu HSWenD Ogden SG et al. Isolation of the neu/HER-2 stimulatory ligand: A 44 kDa glycoprotein that induces differentiation of mammary tumor cells. Cell 1992;69:205-216
13. Steinthorsdottir V Stefansson H Ghosh S Birgisdottir B Bjornsdottir S Fasquel AC et al. Multiple novel transcription initiation sites for NRG1. Gene 2004;342:97-105
14. Mei L Xiong W-C. Neuregulin 1 in neural development synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008;9:437-452
15. Meyer D Yamaai T Garratt A Riethmacher-Sonnenberg E Kane D Theill LE et al. Isoform-specific expression and function of neuregulin. Dev Camb Engl 1997;124: 3575-3586
16. MagnussonS Petersen TE Sottrup-Jensen L ClaeysH. in Proteases and Biological Control: Reich E Rifkin DB Shaw E eds. 123-149 (Cold Spring Harbor Laboratory New York 1975
17. Patthy L Trexler M Váli Z Bányai L Váradi A. Kringles: Modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases FEBS Lett 1984;171:131-136
18. Halaby DM Poupon A Mornon J. The immunoglobulin fold family: Sequence analysis and 3D structure comparisons. Protein Eng 1999;12:563-571
19. Jacobsen NE Abadi N Sliwkowski MX Reilly D Skelton NJ Fairbrother WJ. Highresolution solution structure of the EGF-like domain of heregulin-Alpha. Biochemistry (Mosc) 1996;35:3402-3417
20. Rosnack KJ Stroh JG Singleton DH Guarino BC Andrews GC. Use of capillary electrophoresis-electrospray ionization mass spectrometry in the analysis of synthetic peptides. J Chromatogr A 1994;675:219-225
21. Lu HS Chang D Philo JS Zhang K Narhi LO Liu N et al. Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Similarities and differences of the alpha and beta isoforms. J Biol Chem 1995;270:4784-4791
22. Marikovsky M Lavi S Pinkas-Kramarski R Karunagaran D Liu NWen D et al. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene 1995;10:1403-1411
23. Cote GM Miller TA LeBrasseur NK Kuramochi Y Sawyer DB. Neuregulin-1a and b isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Exp Cell Res 2005;311:135-146
24. Hobbs SS Coffing SL Le AT Cameron EM Williams EE Andrew M et al. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 2002; 21:8442-8452
25. Li L Cleary S Mandarano MA LongW Birchmeier C Jones FE et al. The breast protooncogene HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland. Oncogene 2002;21:4900-4907
26. Plowman GD Green JM Culouscou JM Carlton GW Rothwell VM Buckley S et al. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 1993;366: 473-475
27. Carraway KL III Sliwkowski MX Akita R Platko JV Guy PM Nuijens A et al. The erbB3 gene product is a receptor for heregulin. J Biol Chem 1994;269:14303-14306
28. Dammann CEL Nielsen HC Carraway KL III. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 2003;167:1711-1716
29. Liu J Nethery D Kern JA. Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway. Exp Lung Res 2004;30:465-478
30. Brown DJ Lin B Holguin B. Expression of neuregulin 1 a member of the epidermal growth factor family is expressed as multiple splice variants in the adult human cornea. Invest Ophthalmol Vis Sci 2004;45:3021-3029
31. ChoiWWolber R GerwatW Mann T Batzer J Smuda Cet al. The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin. J Cell Sci 2010;123:3102-3111
32. Lebrasseur NK Coté GM Miller TA Fielding RA Sawyer DB. Regulation of neuregulin/ ErbB signaling by contractile activity in skeletal muscle.AmJ Physiol Cell Physiol 2003;284: C1149-C1155
33. LeBrasseur NK Mizer KC Parkington JD Sawyer DB Fielding RA. The expression of neuregulin and erbB receptors in human skeletal muscle: Effects of progressive resistance training. Eur J Appl Physiol 2005;94:371-375
34. Yang Y Spitzer E Meyer D Sachs M NiemannC HartmannGet al. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 1995;131:215-226
35. Tang CS Ngan ES Tang WK So MT Cheng G Miao XP et al. Mutations in the NRG1 gene are associated with Hirschsprung disease. Hum Genet 2012;131:67-76
36. PatelNV Acarregui MJ Snyder JM Klein JM Sliwkowski MX Kern JA. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. Am J Respir Cell Mol Biol 2000;22:432-440
37. Falls DL Rosen KM Corfas G Lane WS Fischbach GD. ARIA a protein that stimulates acetylcholine receptor synthesis is a member of the neu ligand family. Cell 1993;72: 801-815
38. WenD Peles E Cupples R Suggs SV Bacus SS Luo Y et al. Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 1992;69:559-572
39. HolmesWESliwkowski MXAkitaRW Henzel WJ Lee J ParkJWet al. Identification of heregulin a specific activator of p185erbB2. Science 1992;256:1205-1210
40. Liu X Bates R Yin DM Shen CWang F SuNet al. Specific regulation ofNRG1 isoform expression by neuronal activity. J Neurosci Off J Soc Neurosci 2011;31:8491-8501
41. Zhao YY Sawyer DR Baliga RR Opel DJ Han X Marchionni MA et al. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998;273: 10261-10269
42. HoWHArmaniniMP Nuijens A Phillips HS Osheroff PL. Sensory and motor neuronderived factor. A novel heregulin variant highly expressed in sensory and motor neurons. J Biol Chem 1995;270:14523-14532
43. Abe Y Namba H Kato T Iwakura Y Nawa H. Neuregulin-1 signals from the periphery regulate AMPA receptor sensitivity and expression in GABAergic interneurons in Developing neocortex. J Neurosci Off J Soc Neurosci 2011;31:5699-5709
44. TanWWang Y Gold B Chen J Dean M Harrison PJ et al. Molecular cloning of a brainspecific developmentally regulatedneuregulin 1(NRG1)isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 2007;282: 24343-24351
45. Busfield SJ Michnick DA Chickering TW Revett TL Ma JWoolf EA et al. Characterization of a neuregulin-related gene Don-1 that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol Cell Biol 1997;17:4007-4014
46. Higashiyama S HorikawaM Yamada K Ichino N Nakano N Nakagawa T et al. A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4. J Biochem (Tokyo) 1997;122:675-680
47. Falls DL. Neuregulins: Functions forms and signaling strategies. Exp Cell Res 2003;284: 14-30
48. Ni C-Y Murphy MP Golde TE Carpenter G. g-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001;294:2179-2181
49. Hatzimanolis A McGrath JAWang R Li TWong PC NestadtGet al. Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients. Transl Psychiatry 2013;3:e264
50. Pedrique SP Fazzari P. Nrg1 reverse signaling in cortical pyramidal neurons. J Neurosci Off J Soc Neurosci 2010;30:15005-15006
51. Sardi SP Murtie J Koirala S Patten BA Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 2006;127: 185-197
52. Burgess TL Ross SL Qian YX Brankow D Hu S. Biosynthetic processing of neu differentiation factor. Glycosylation trafficking and regulated cleavage from the cell surface. J Biol Chem 1995;270:19188-19196
53. Fleck D van Bebber F Colombo A Galante C Schwenk BM Rabe L et al. Dual cleavage of neuregulin 1 type III byBACE1 andADAM17liberates its EGF-like domain and allows paracrine signaling. J Neurosci Off J Soc Neurosci 2013;33:7856-7869
54. Montero JC Yuste L Díaz-Rodríguez E Esparís-Ogando A Pandiella A. Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-Alpha-converting enzyme. Mol Cell Neurosci 2000;16:631-648
55. Shirakabe K Wakatsuki S Kurisaki T Fujisawa-Sehara A. Roles of Meltrin beta/ ADAM19 in the processing of neuregulin. J Biol Chem 2001;276:9352-9358
56. Horiuchi K Zhou H-M Kelly K Manova K Blobel CP. Evaluation of the contributions of ADAMs 9 12 15 17 and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev Biol 2005;283:459-471
57. Luo X Prior M HeW Hu X Tang X ShenWet al. Cleavage of neuregulin-1 by BACE1 orADAM10 protein produces differential effects on myelination. J Biol Chem 2011;286: 23967-23974
58. Bao J Lin H Ouyang Y Lei D Osman A KimTWet al. Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci 2004;7:1250-1258
59. Nural-Guvener HF Mutlu N Gaballa MA. BACE1 levels are elevated in congestive heart failure. Neurosci Lett 2013;532:7-11
60. Liu X Hwang H Cao L Buckland M Cunningham A Chen J et al. Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail. Proc Natl Acad Sci USA 1998;95:13024-13029
61. Dang M Dubbin K DAiello A Hartmann M Lodish H Herrlich A et al. Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus. J Biol Chem 2011; 286:17704-17713
62. Graus-Porta D Beerli RR Daly JM Hynes NE. ErbB-2 the preferred heterodimerization partner of all ErbB receptors is a mediator of lateral signaling. EMBO J 1997;16: 1647-1655
63. Yarden Y Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-137
64. Guy PM Platko JV Cantley LC Cerione RA Carraway KL III. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 1994;91:8132-8136
65. Berger MB Mendrola JM Lemmon MA. ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface. FEBS Lett 2004;569:332-336
66. SweeneyC CarrawayKL III. Ligand discrimination by ErbB receptors: Differential signaling through differential phosphorylation site usage. Oncogene 2000;19:5568-5573
67. Lee KF Simon H Chen H Bates B Hung MC Hauser C et al. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995;378:394-398
68. Gassmann M Casagranda F Orioli D Simon H Lai C Klein R et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995;378: 390-394
69. Liu J Bressan M Hassel D Huisken J Staudt D Kikuchi K et al. A dual role for ErbB2 signaling in cardiac trabeculation. Dev Camb Engl 2010;137:3867-3875
70. Sweeney C Lai C Riese DJ II Diamonti AJ Cantley LC Carraway KL III. Ligand discrimination in signaling through an ErbB4 receptor homodimer. J Biol Chem 2000;275: 19803-19807
71. Crovello CS Lai C Cantley LC Carraway KL III. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2. J Biol Chem 1998;273: 26954-26961
72. Yamada K Ichino N Nishii K Sawada H Higashiyama S Ishiguro H et al. Characterization of the human NTAK gene structure and distribution of the isoforms for ratNTAK mRNA. Gene 2000;255:15-24
73. Meyer D Birchmeier C. Multiple essential functions of neuregulin in Development. Nature 1995;378:386-390
74. Baliga RR Pimental DR Zhao YY Simmons WW Marchionni MA Sawyer DB et al. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase p70(S6K) and MEK-MAPK-RSK. Am J Physiol 1999;277:H2026-H2037
75. Liu J Kern JA. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol 2002;27:306-313
76. Hertig CM Kubalak SW Wang Y Chien KR. Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis. J Biol Chem 1999;274:37362-37369
77. Kramer R Bucay N Kane DJ Martin LE Tarpley JE Theill LE. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci USA 1996;93:4833-4838
78. Britto JM Lukehurst SWeller R Fraser C Qiu Y Hertzog P et al. Generation and characterization of neuregulin-2-deficient mice. Mol Cell Biol 2004;24:8221-8226
79. Stö llberger C Finsterer J. Left ventricular hypertrabeculation/ noncompaction. J AmSoc Echocardiogr Off Publ Am Soc Echocardiogr 2004;17:91-100
80. ShiW Chen H Sun J Buckley S Zhao J Anderson KD et al. TACE is required for fetal murine cardiac development and modeling. Dev Biol 2003;261:371-380
81. Camenisch TD Schroeder JA Bradley J Klewer SE McDonald JA. Heart-valve mesenchyme formation is dependent on hyaluronan-Augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002;8:850-855
82. Erickson SL OShea KS Ghaboosi N Loverro L Frantz G Bauer M et al. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2-And heregulin-deficient mice. Dev Camb Engl 1997;124:4999-5011
83. Rentschler S Zander J Meyers K France D Levine R PorterGet al. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci USA 2002; 99:10464-10469
84. Hedhli N Huang Q Kalinowski A Palmeri M Hu X Russell RR et al. Endotheliumderived neuregulin protects the heart against ischemic injury. Circulation 2011;123: 2254-2262
85. Fuller SJ Sivarajah K Sugden PH. ErbB receptors their ligands and the consequences of their activation and inhibition in the myocardium. J Mol Cell Cardiol 2008;44:831-854
86. Jay SM Murthy AC Hawkins JFWortzel JR Steinhauser ML Alvarez LM et al. An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. Circulation 2013;128:152-161
87. Bersell K Arab S Haring B Kühn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009;138:257-270
88. Li B Zheng ZWeiYWang M Peng J KangTet al. Therapeutic effects of neuregulin-1 in Diabetic cardiomyopathy rats. Cardiovasc Diabetol 2011;10:69
89. Timolati F Ott D Pentassuglia L Giraud MN Perriard JC Suter TM et al. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. J Mol Cell Cardiol 2006;41: 845-854
90. Fukazawa RMillerTAKuramochiY FrantzSKimYDMarchionniMAet al.Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol 2003;35:1473-1479
91. Bian Y Sun M Silver M Ho KK Marchionni MA Caggiano AOet al. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol 2009;297:H1974-H1983
92. Sawyer DB Zuppinger C Miller TA Eppenberger HM Suter TM. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1 beta and anti-erbB2: Potential mechanism for trastuzumab-induced cardiotoxicity. Circulation 2002;105:1551-1554
93. Lemmens K Fransen P Sys SU Brutsaert DLDe KeulenaerGW. Neuregulin-1 induces a negative inotropic effect in cardiac muscle: Role of nitric oxide synthase. Circulation 2004;109:324-326
94. Bian Y Silver M Ho KKL Marchionni MA Kang PM Goukassian DA et al. Neuregulin1 improved cardiac function in Doxorubicin-Treated mice with cardiomyocyte-specific over expression of a dominant-negative PI3Kp110a. J Cardiovasc Dis Diagn 2013;01:120
95. Iivanainen E Paatero I Heikkinen SM Junttila TT Cao R Klint P et al. Intra- And extracellular signaling by endothelial neuregulin-1. Exp Cell Res 2007;313:2896-2909
96. Russell KS Stern DF Polverini PJ Bender JR. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am J Physiol 1999;277:H2205-H2211
97. Matsukawa R Hirooka Y Nishihara M Ito K Sunagawa K. Neuregulin-1/ErbB signaling in rostral ventrolateral medulla is involved in blood pressure regulation as an antihypertensive system. J Hypertens 2011;29:1735-1742
98. Hill MF Patel AVMurphyA SmithHMGalindo CL Pentassuglia L et al. Intravenous glial growthfactor2(GGF2) isoformofneuregulin-1bimproves leftventricular functiongene and protein expression in rats after myocardial infarction. PloS ONE 2013;8:e55741.
99. Brero A Ramella R Fitou A Dati C Alloatti G Gallo MP et al. Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes. Cardiovasc Res 2010;88:443-452
100. Liu XGuX Li Z Li X Li H Chang J et al. Neuregulin-1/erbB-Activation improves cardiac function and survival in models of ischemic dilated and viral cardiomyopathy. J Am Coll Cardiol 2006;48:1438-1447
101. Hervent A-S Vandekerckhove L KeulenaerGWD.Neuregulin-1 antagonizes myocardial fibrosis and diastolic dysfunction in angiotensin-II treated mice. Eur Heart J 2013;34: P2434
102. Crone SA Zhao YY Fan L Gu Y Minamisawa S Liu Y et al. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 2002;8:459-465
103. Ozcelik C Erdmann B Pilz BWettschureck N Britsch S Hübner N et al. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci USA 2002;99:8880-8885
104. Rohrbach S Yan XWeinberg EO Hasan F Bartunek J MarchionniMAet al. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors. Circulation 1999;100:407-412
105. Reiss K Cheng W Ferber A Kajstura J Li P Li B et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 1996;93:8630-8635
106. Kühn B del Monte F Hajjar RJ Chang YS Lebeche D Arab S et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007;13:962-969
107. Engel FB Hsieh PCH Lee RT Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis reduces scarring and rescues function after myocardial infarction. Proc Natl Acad Sci 2006;103:15546-15551
108. Cittadini A Strömer H Katz SE Clark R MosesAC Morgan JP et al. Differential cardiac effects of growth hormone and insulin-like growth factor1 in the rat.Acombined in vivo and in vitro evaluation. Circulation 1996;93:800-809
109. Oka T Xu J Kaiser RA Melendez J Hambleton M Sargent MA et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007;101:313-321
110. Li B Xiao J Li Y Zhang J Zeng M. Gene transfer of human neuregulin-1 attenuates ventricular remodeling in Diabetic cardiomyopathy rats. Exp Ther Med 2013;6:1105-1112
111. An T Zhang Y Huang Y Zhang R Yin S Guo X et al. Neuregulin-1 protects against doxorubicin-induced apoptosis in cardiomyocytes through an Akt-dependent pathway. Physiol Res Acad Sci Bohemoslov 2013;62:379-385
112. Buerke M Murohara T Skurk C Nuss C Tomaselli K LeferAMet al. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci 1995;92:8031-8035
113. Cuevas P Reimers D Carceller F Martinez-Coso V Redondo-Horcajo M Saenz de Tejada I et al. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur J Med Res 1997;2:465-468
114. Iwai-Kanai E Hasegawa K Fujita M Araki M Yanazume T Adachi S et al. Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 2002;190:54-62
115. Zhang GWWen T Gu TX Li-Ling JWang C Zhao Y et al. Transmyocardial drilling revascularization combined with heparinized bFGF-incorporating stent activates resident cardiac stem cells via SDF-1/CXCR4 axis. Exp Cell Res 2012;318:391-399
116. Zhao Z Rivkees SA. Programmed cell death in the developing heart: Regulation by BMP4 and FGF2. Dev Dyn Off Publ Am Assoc Anat 2000;217:388-400
117. Brar BK Jonassen AK Stephanou A Santilli G Railson J Knight RA et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 2000;275:8508-8514
118. Friehs I Barillas R Vasilyev NV Roy N McGowan FX del Nido PJ et al. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart. Circulation 2006;114:I290-I295
119. Yang BC Zander DS Mehta JL. Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-b1. J Pharmacol Exp Ther 1999;291:733-738
120. BaxterGF Mocanu MM Brar BK Latchman DS YellonDM. Cardioprotective effects of transforming growth factor-b1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol 2001;38:930-939
121. Chen H Li D Saldeen T Mehta JL. TGF-b1 modulatesNOSexpression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 2001;281:H1035-H1039
122. Sheng Z Knowlton K Chen J Hoshijima M Brown JH Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-Activated protein kinasedependent pathway divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 1997;272:5783-5791
123. SuterTM Cook-Bruns N Barton C. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer. Breast Edinb Scotl 2004;13: 173-183
124. Rohrbach S Niemann B Silber R-E Holtz J. Neuregulin receptors erbB2 and erbB4 in failing human myocardium-depressed expression and attenuated activation. Basic Res Cardiol 2005;100:240-249
125. Doggen K Ray L Mathieu M Mc Entee K Lemmens K De KeulenaerGW. Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. J Mol Cell Cardiol 2009;46:33-38
126. McBride KL Zender GA Fitzgerald-Butt SM Seagraves NJ Fernbach SD ZapataGet al. Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction Defects. Birt Defects Res A Clin Mol Teratol 2011;91:162-168
127. Gui C Zhu L Hu M Lei L Long Q. Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy. Cardiovasc Pathol Off J Soc Cardiovasc Pathol 2012; 21:414-420
128. Ky B Kimmel SE Safa RN Putt ME Sweitzer NK Fang JC et al. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation 2009;120:310-317
129. Geisberg CA Wang G Safa RN Smith HM Anderson B Peng XY et al. Circulating neuregulin-1b levels vary according to the angiographic severity of coronary artery disease and ischemia. Coron Artery Dis 2011;22:577-582
130. Hedhli N Dobrucki LW Kalinowski A Zhuang ZW Wu X Russell RR III et al. Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis. Cardiovasc Res 2012;93:516-524
131. Lemmens K Segers VFM DemolderM De KeulenaerGW. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-Talk. J BiolChem2006;281:19469- 19477
132. Ingber D. Integrins as mechanochemical transducers. Curr Opin Cell Biol 1991;3: 841-848
133. Ieguchi K Fujita M Ma Z Davari P Taniguchi Y Sekiguchi K et al. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling. J Biol Chem 2010;285:31388-31398
134. Lemmens K Doggen K De Keulenaer GW. Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy. Am J Physiol Heart Circ Physiol 2011;300:H931-H942
135. Kloch-Badelek M Kuznetsova T Sakiewicz W Tikhonoff V Ryabikov A González A et al. Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds. Cardiovasc Ultrasound 2012;10:10
136. Desai CS Colangelo LA Liu K Jacobs DR Jr Cook NL Lloyd-Jones DM et al. Prevalence prospective risk markers and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: The coronary artery risk development in young adults study. Am J Epidemiol 2013;177:20-32
137. Kuznetsova T Herbots L López B Jin Y Richart T Thijs L et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2009;2:105-112
138. Gu X Liu X Xu D Li X Yan M Qi Y et al. Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Cardiovasc Res 2010;88:334-343
139. Chang AN Huang J Battiprolu PK Hill JA Kamm KE Stull JT. The effects of neuregulin on cardiac myosin light chain kinase gene-Ablated hearts. PloS ONE 2013;8:e66720
140. Ebner B Lange SA Eckert T Wischniowski C Ebner A Braun-Dullaeus RC et al. Uncoupled eNOS annihilates neuregulin-1b-induced cardioprotection: A novel mechanism in pharmacological postconditioning in myocardial infarction. Mol Cell Biochem 2013;373:115-123
141. Yu D Hung MC. Overexpression of ErbB2 in cancer and ErbB2-Targeting strategies. Oncogene 2000;19:6115-6121
142. Wang SE Narasanna A Perez-Torres M Xiang B Wu FY Yang S et al. HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell 2006;10:25-38
143. Alajati A SausgruberN Aceto N Duss S Sarret S VosholH et al.Mammary tumor formation andmetastasis evoked by a HER2 splice variant. Cancer Res 2013;73:5320-5327
144. Chua YL ItoY Pole JCNewmanS Chin SF SteinRCet al. TheNRG1gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. Oncogene 2009;28:4041-4052
145. Schaefer G Fitzpatrick VD Sliwkowski MX. Gamma-heregulin: A novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line MDA-MB-175. Oncogene 1997;15:1385-1394
146. Wang XZ Jolicoeur EM ConteN ChaffanetM Zhang Y MozziconacciMJ et al. gamma-Heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/ NRG1genes in theMDA-MB-175 breast cancer cell line.Oncogene 1999;18:5718-5721
147. Adélaïde J Huang HE Murati A Alsop AE Orsetti B Mozziconacci MJ et al.Arecurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Genes Chromosomes Cancer 2003;37:333-345
148. Huang HE Chin SF Ginestier C Bardou VJ Adélaïde J Iyer NG et al. A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene. Cancer Res 2004;64:6840-6844
149. Prentice LM Shadeo A Lestou VS Miller MA deLeeuw RJ Makretsov N et al. NRG1 gene rearrangements in clinical breast cancer: Identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 2005;24:7281-7289
150. Mittra I Redkar AA Badwe RA. Prognosis of breast cancer: Evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes. J Surg Oncol 1995;60:106-111
151. Agrup M Stal O Olsen K Wingren S. C-erbB-2 overexpression and survival in early onset breast cancer. Breast Cancer Res Treat 2000;63:23-29
152. Jabbour AHayward CS Keogh AM Kotlyar E McCrohonJA England JF et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 2011;13:83-92
153. Gao R Zhang J Cheng LWuX DongW YangX et al. A phase II randomized doubleblind multicenter based on standard therapy placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol 2010;55:1907-1914
154. Polizzotti BD Arab S Kühn B. Intrapericardial delivery of gelfoam enables the targeted delivery of periostin peptide after myocardial infarction by inducing fibrin clot formation. PLoS ONE 2012;7:e36788
155. Stefansson H Sigurdsson E Steinthorsdottir V Bjornsdottir S Sigmundsson T Ghosh S et al.Neuregulin 1 and susceptibility toschizophrenia. AmJHumGenet2002;71:877-892
156. Rö sler TW Depboylu C Arias-CarriónOWoznyW Carlsson T Hö llerhage M et al. Biodistribution and brain permeability of the extracellular domain of neuregulin-1-b1. Neuropharmacology 2011;61:1413-1418
157. Kastin AJ Akerstrom V Pan W. Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport. J Neurochem 2004;88:965-970